Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024Business Wire • 04/18/24
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeBusiness Wire • 03/26/24
Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery PatientsBusiness Wire • 03/19/24
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial ResultsBusiness Wire • 03/05/24
Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024Business Wire • 02/20/24
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business UpdateBusiness Wire • 01/08/24
Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital MarketplaceBusiness Wire • 11/01/23
Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023Business Wire • 10/19/23
Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual MeetingBusiness Wire • 10/10/23
Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources OfficerBusiness Wire • 09/27/23
Cerus Corporation to Participate in the 2023 Cantor Global Healthcare ConferenceBusiness Wire • 09/12/23
5 Stocks Wall Street and ARK's Cathie Wood Love Are Trading Under $10 With Huge Upside Potential24/7 Wall Street • 08/26/23
Cathie Wood's ARK Funds Are Loading Up on These 5 Red-Hot Stocks Trading Under $1024/7 Wall Street • 08/12/23
Cathie Wood's ARK Funds Include 5 ‘Strong Buy' Stocks Under $10 With Huge Upside Potential24/7 Wall Street • 07/29/23
Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023Business Wire • 07/19/23
5 Stocks Under $10 With Massive Upside Potential and ARK's Cathie Wood Loves Two of Them24/7 Wall Street • 07/15/23